148 related articles for article (PubMed ID: 36639599)
21. High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China.
Sun L; Hu W; Liu M; Chen Y; Jin B; Xu H; Du S; Xu Y; Zhao H; Lu X; Sang X; Zhong S; Yang H; Mao Y
Cancer Res Treat; 2020 Oct; 52(4):1199-1210. PubMed ID: 32718144
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
23. Development of a nomogram prognostic model for early Grade ≥ 3 infection in newly diagnosed multiple myeloma based on immunoparesis.
Zhang M; Cheng Q; Zhao F; Xu A; Li Q; Hu Y; Sun C
Int Immunopharmacol; 2024 Jan; 126():111277. PubMed ID: 38061120
[TBL] [Abstract][Full Text] [Related]
24. Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells.
Zhao M; Duan X; Han X; Wang J; Han G; Mi L; Shi J; Li N; Yin X; Hou J; Yin F
Front Oncol; 2022; 12():854096. PubMed ID: 35463384
[TBL] [Abstract][Full Text] [Related]
25. Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma.
Xu X; Jing J
Front Oncol; 2022; 12():900305. PubMed ID: 36338698
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.
Wang S; Deng Y; Yu X; Zhang XW; Huo CL; Sun ZG; Chang H
Sci Rep; 2021 Jul; 11(1):13814. PubMed ID: 34226605
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between Peripheral Blood PLR with Treg, Th17 in Newly Diagnosed Multiple Myeloma and Its Influence on Prognosis].
Qin N; Feng RT; Wang X; Guo SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1757-1763. PubMed ID: 38071057
[TBL] [Abstract][Full Text] [Related]
28. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.
Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X
J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985
[No Abstract] [Full Text] [Related]
29. Development and Validation of a Nomogram Model Based on Hematological Indicators for Predicting the Prognosis of Diffused Gliomas.
Han S; Qu FW; Wang PF; Liu YX; Li SW; Yan CX
Front Surg; 2022; 9():803237. PubMed ID: 35495765
[TBL] [Abstract][Full Text] [Related]
30. A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Xin Y; Zhang X; Li Y; Yang Y; Chen Y; Wang Y; Zhou X; Li X
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):43-53. PubMed ID: 34561739
[TBL] [Abstract][Full Text] [Related]
31. Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study.
Wang HK; Wei Q; Yang YL; Lu TY; Yan Y; Wang F
Cancer Cell Int; 2023 Jan; 23(1):13. PubMed ID: 36707809
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of preoperative systemic inflammation response index in newly diagnosed glioblastoma patients underwent gross total resection: a propensity score matching analysis.
Wang Z; Li J; Yuan Y; Li T; Zuo M; Liu Y
World J Surg Oncol; 2022 Apr; 20(1):137. PubMed ID: 35488347
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients.
Jin B; Hu W; Su S; Xu H; Lu X; Sang X; Yang H; Mao Y; Du S
Cancer Manag Res; 2021; 13():6263-6277. PubMed ID: 34408489
[TBL] [Abstract][Full Text] [Related]
34. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma.
Liang S; Li C; Gao Z; Li J; Zhao H; Yu J; Meng X
Int Immunopharmacol; 2021 Jan; 90():107178. PubMed ID: 33218939
[TBL] [Abstract][Full Text] [Related]
35. The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients.
Qi J; Zhang J; Ge X; Wang X; Xu L; Liu N; Zhao L; Wang P
Front Oncol; 2021; 11():713014. PubMed ID: 34692490
[TBL] [Abstract][Full Text] [Related]
36. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage.
Wang RH; Wen WX; Jiang ZP; Du ZP; Ma ZH; Lu AL; Li HP; Yuan F; Wu SB; Guo JW; Cai YF; Huang Y; Wang LX; Lu HJ
Front Immunol; 2023; 14():1115031. PubMed ID: 36860868
[TBL] [Abstract][Full Text] [Related]
37. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.
Li XH; Chang H; Xu BQ; Tao YL; Gao J; Chen C; Qu C; Zhou S; Liu SR; Wang XH; Zhang WW; Yang X; Zhou SL; Xia YF
Cancer Med; 2017 Jan; 6(1):310-319. PubMed ID: 27860387
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a novel nomogram for predicting systemic inflammatory response syndrome's occurrence in patients undertaking flexible ureteroscopy.
Xuan Z; Yu Z; Tan G; Ding N; He H; Yu S; Liu G; Zhu X; Zhu B; Liu Z
Transl Androl Urol; 2022 Feb; 11(2):228-237. PubMed ID: 35280653
[TBL] [Abstract][Full Text] [Related]
39. Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple Myeloma.
Yang Y; Liu Z; Wang H
Med Sci Monit; 2020 Jul; 26():e923716. PubMed ID: 32732863
[TBL] [Abstract][Full Text] [Related]
40. Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy.
Kamposioras K; Papaxoinis G; Dawood M; Appleyard J; Collinson F; Lamarca A; Ahmad U; Hubner RA; Wright F; Pihlak R; Damyanova I; Razzaq B; Valle JW; McNamara MG; Anthoney A
Acta Oncol; 2022 May; 61(5):583-590. PubMed ID: 35392758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
